Furthermore, we cannot exclude the possibility that Sesn2 levels were affected by the use of ICS since patients with emphysema used significantly less ICS compared to non-emphysema COPD patients although further studies are needed to evaluate the possible effect of ICS in Sesn2 levels in COPD patients. The gene discussed is SESN2; the disease is pulmonary emphysema.